PARAMETRIC PORTFOLIO ASSOCIATES LLC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 193 filers reported holding MYRIAD GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q1 2022$5,724,000
-17.0%
227,160
-9.0%
0.00%
-25.0%
Q4 2021$6,893,000
-22.5%
249,757
-9.4%
0.00%
-20.0%
Q3 2021$8,897,000
-24.7%
275,522
-28.6%
0.01%
-28.6%
Q2 2021$11,808,000
+3.4%
386,142
+2.9%
0.01%0.0%
Q1 2021$11,424,000
+74.9%
375,187
+13.6%
0.01%
+75.0%
Q4 2020$6,531,000
+121.0%
330,243
+45.7%
0.00%
+100.0%
Q3 2020$2,955,000
+129.8%
226,625
+99.8%
0.00%
+100.0%
Q2 2020$1,286,000
-27.3%
113,443
-8.2%
0.00%
-50.0%
Q1 2020$1,768,000
-68.0%
123,558
-39.2%
0.00%
-50.0%
Q4 2019$5,532,000
-26.8%
203,161
-23.1%
0.00%
-33.3%
Q3 2019$7,561,000
-4.1%
264,110
-7.0%
0.01%
-14.3%
Q2 2019$7,888,000
-37.0%
283,951
-24.7%
0.01%
-36.4%
Q1 2019$12,526,000
-1.6%
377,276
-13.9%
0.01%
-15.4%
Q4 2018$12,736,000
-17.9%
438,103
+29.9%
0.01%
-7.1%
Q3 2018$15,520,000
+22.4%
337,381
-0.5%
0.01%
+16.7%
Q2 2018$12,676,000
+26.4%
339,192
-0.1%
0.01%
+20.0%
Q1 2018$10,032,000
-23.0%
339,481
-10.5%
0.01%
-23.1%
Q4 2017$13,026,000
+1.8%
379,281
+7.2%
0.01%
-7.1%
Q3 2017$12,796,000
+47.3%
353,673
+5.2%
0.01%
+40.0%
Q2 2017$8,688,000
+77.7%
336,234
+32.1%
0.01%
+42.9%
Q1 2017$4,889,000
+160.3%
254,623
+126.1%
0.01%
+133.3%
Q4 2016$1,878,000
-25.8%
112,630
-8.5%
0.00%
-25.0%
Q3 2016$2,532,000
-33.0%
123,049
-0.4%
0.00%
-33.3%
Q2 2016$3,780,000
-39.3%
123,532
-25.8%
0.01%
-40.0%
Q1 2016$6,229,000
+39.8%
166,427
+61.1%
0.01%
+25.0%
Q4 2015$4,457,000
+37.8%
103,277
+19.7%
0.01%
+33.3%
Q3 2015$3,235,000
+125.3%
86,311
+104.2%
0.01%
+100.0%
Q2 2015$1,436,000
-16.0%
42,261
-12.5%
0.00%0.0%
Q1 2015$1,710,000
+6.8%
48,291
+2.7%
0.00%0.0%
Q4 2014$1,601,000
-4.0%
47,018
+8.8%
0.00%
-25.0%
Q3 2014$1,667,000
-2.6%
43,218
-1.7%
0.00%0.0%
Q2 2014$1,712,000
+39.6%
43,984
+22.6%
0.00%
+33.3%
Q1 2014$1,226,000
+143.3%
35,862
+49.2%
0.00%
+200.0%
Q4 2013$504,000
-62.4%
24,034
-57.8%
0.00%
-75.0%
Q3 2013$1,339,000
-32.3%
56,969
-22.6%
0.00%
-33.3%
Q2 2013$1,978,00073,6000.01%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$98,875,0003.47%
Tieton Capital Management, LLC 187,636$3,711,0002.72%
Glenview Capital Management 3,682,691$72,825,0001.67%
Altium Capital Management LP 218,650$4,324,0001.61%
S&T BANK/PA 331,098$6,547,0001.18%
EARNEST PARTNERS LLC 6,731,429$133,114,0000.92%
DISCIPLINED GROWTH INVESTORS INC /MN 2,078,075$41,094,0000.79%
SummerHaven Investment Management, LLC 35,700$706,0000.55%
AIMZ Investment Advisors, LLC 42,685$844,0000.44%
CONTINENTAL ADVISORS LLC 36,392$720,0000.33%
View complete list of MYRIAD GENETICS INC shareholders